trial

fMRI Cholinergic Mechanisms in Schizophrenia

NCTId NCT01191827
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Completed
Enrollment 40 (actual)
Sponsored by US Department of Veterans Affairs
Primary completion 2011-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
40 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2008-10
Primary completion
2011-12
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
—

Sponsors

US Department of Veterans AffairsLead Sponsor

Investigators

1
Jason R. Tregellas, PhDPrincipal Investigator

Sites

1 total
Denver, United States

Facts & assertions

4 sourced
Enrollment
40
Phase
NA
Primary Completion Date
2011-12
Status
COMPLETED
relationships
The graph out of here
lead_sponsor
US Department of Veterans Affairs
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Jason R. Tregellas, PhD
person